EVEREST ORGANICS
Quarterly Results Analysis [Mar2025]
EVEREST ORGANICS Quarterly Results
Standalone | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹41 Cr | ₹42 Cr | ₹44 Cr | ₹32 Cr | ₹53 Cr | ₹53 Cr | ₹49 Cr | ₹43 Cr |
Expenses | ₹37 Cr | ₹38 Cr | ₹41 Cr | ₹36 Cr | ₹50 Cr | ₹50 Cr | ₹47 Cr | ₹40 Cr |
Operating Income | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹-4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹-6 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Profit After Tax | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹-6 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
EPS | ₹3.00 | ₹1.43 | ₹0.92 | ₹-7.61 | ₹0.07 | ₹0.02 | ₹0.04 | ₹0.04 |
Industry Peers & Returns | 1W | 1M | 1Y |
EVEREST ORGANICS | -4% | -7.1% | 102.1% |
SUN PHARMACEUTICAL INDUSTRIES | -4.3% | -3% | -0.7% |
DIVIS LABORATORIES | -3.3% | -7.4% | 34.1% |
CIPLA | -4.4% | -0.5% | 0.7% |
TORRENT PHARMACEUTICALS | 1.4% | 10.1% | 17.9% |
DR REDDYS LABORATORIES | -5.2% | -5.7% | -5.9% |
MANKIND PHARMA | 0.8% | 8.4% | 26.4% |
ZYDUS LIFESCIENCES | -3.1% | -5.1% | -22.2% |
LUPIN | -4.9% | -4.6% | 0.9% |
EVEREST ORGANICS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -2.65 % |
Y-o-Y | -22.20 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹41 Cr | -2.65 | |
Dec2024 | ₹42 Cr | -4.53 | |
Sep2024 | ₹44 Cr | 35.75 | |
Jun2024 | ₹32 Cr | -38.34 | |
Mar2024 | ₹53 Cr | 0.21 | |
Dec2023 | ₹53 Cr | 6.19 | |
Sep2023 | ₹49 Cr | 15.88 | |
Jun2023 | ₹43 Cr | - |
EVEREST ORGANICS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -14.46 % |
Y-o-Y | 16.11 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹3 Cr | -14.46 | |
Dec2024 | ₹4 Cr | 17.31 | |
Sep2024 | ₹3 Cr | Positive | |
Jun2024 | ₹-4 Cr | Negative | |
Mar2024 | ₹3 Cr | 5.79 | |
Dec2023 | ₹3 Cr | 3.36 | |
Sep2023 | ₹3 Cr | 7.38 | |
Jun2023 | ₹3 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -12.13 % |
Y-o-Y | 49.20 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 8.4% | -12.13 | |
Dec2024 | 9.56% | 22.88 | |
Sep2024 | 7.78% | Positive | |
Jun2024 | -11.27% | Negative | |
Mar2024 | 5.63% | 5.63 | |
Dec2023 | 5.33% | -2.56 | |
Sep2023 | 5.47% | -7.45 | |
Jun2023 | 5.91% | - |
EVEREST ORGANICS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 155.21 % |
Y-o-Y | 4,920.69 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹3 Cr | 155.21 | |
Dec2024 | ₹1 Cr | 54.19 | |
Sep2024 | ₹1 Cr | Positive | |
Jun2024 | ₹-6 Cr | Negative | |
Mar2024 | ₹0 Cr | 241.18 | |
Dec2023 | ₹0 Cr | -41.38 | |
Sep2023 | ₹0 Cr | -14.71 | |
Jun2023 | ₹0 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 162.36 % |
Y-o-Y | 6,363.64 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 7.11 % | 162.36 | |
Dec2024 | 2.71 % | 61.31 | |
Sep2024 | 1.68 % | Positive | |
Jun2024 | -18.77 % | Negative | |
Mar2024 | 0.11 % | 266.67 | |
Dec2023 | 0.03 % | -50.00 | |
Sep2023 | 0.06 % | -25.00 | |
Jun2023 | 0.08 % | - |
EVEREST ORGANICS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 109.79 % |
Y-o-Y | 4,185.71 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹3 | 109.79 | |
Dec2024 | ₹1.43 | 55.43 | |
Sep2024 | ₹0.92 | Positive | |
Jun2024 | ₹-7.61 | Negative | |
Mar2024 | ₹0.07 | 250.00 | |
Dec2023 | ₹0.02 | -50.00 | |
Sep2023 | ₹0.04 | 0.00 | |
Jun2023 | ₹0.04 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD